aqueous ammonia (5 h, 55 °C) and purified by reversed-phase
HPLC (octyl) with a gradient of 0 to 35% CH3CN in 0.1 M
NH4OAc.
The resultant HyBeacon probe (2DC64C*) was designed to
differentiate between a fully complementary DNA target and
one containing a single C.A mismatch. The 2A-FAM ethoxy dU
is adjacent to the polymorphic site, and is therefore sensitive to
changes in Tm caused by mispairing at this locus. Real-time
PCR†¶ indicated that good discrimination was achieved. The
magnitude of the change in fluorescence on hybridisation of
2DC64C* was similar to that for HyBeacons with major groove
fluorophores.4 Post-PCR fluorescence melting analysis (Fig. 2),
a particular advantage of the HyBeacon system, enabled us to
discriminate very clearly between wild-type, heterozygote and
homozygous mutant. These results prove that the fluorescence
enhancement, characteristic of HyBeacon probes, can be readily
achieved using oligonucleotides with fluorophores attached to
the minor groove.
This novel synthetic methodology can be used to incorporate
different fluorescent dyes in the minor groove of DNA to
produce “multi-coloured” HyBeacons, and such probes could
be used in high-throughput genetic analysis to detect several
different SNPs in a single tube. However, the majority of
current genetic analysis platforms have only one fluorescence
excitation source at 495 nm, and in order to utilise all the
available detection channels, fluorescence resonance energy
transfer (FRET) must be used. This can be achieved by
incorporating FAM (FRET donor) and a second fluorescent dye
(FRET acceptor) in the same oligonucleotide.12–14 To explore
the utility of monomer 7 in FRET applications we prepared
dual-labelled oligonucleotide probes P1 & P2 (Fig. 3) with an
internal FAM and 5A-ROX (Scheme 2).
Fig. 3 FRET from FAM to ROX.
to 47 °C for P1 and 44 °C for P2 (1 mM duplex, 100 mM NaCl,
10 mM Na phosphate, pH 7.0). The origin of these differences
is probably twofold; destabilisation due to the presumed C3A-
endo conformation of the modified ribose sugar, and steric
hindrance caused by the bulky 2A-fluorescein moiety. It is clear
from the excellent discrimination in Fig. 2 that the slight
instability does not confer any limitations on the use of our
nucleotide in genetic probes. Similar effects were observed by
Yamana et al.7,8
Energy transfer from FAM to ROX was recorded for the P1
and P2 duplexes in aqueous buffer at RT, pH 7.0 (data not
shown). The fluorescence intensity of ROX (606 nm) was more
than 4-fold greater in P2 than in P1, demonstrating the need to
separate the two dyes to avoid collisional quenching. FRET in
P2 is efficient with a ROX : FAM emission ratio of 8.2 : 1 These
results are most encouraging and indicate that monomer 7 can
be used in the synthesis of dual-labelled probes for a variety of
applications. The properties of dual-labelled hybridisation
probes are currently under further investigation. In conclusion,
we have synthesised a HyBeacon functionalised with 2A-
fluorescein and shown it to be an effective genetic probe. We
have also demonstrated that the 2A-modified FAM dU nucleo-
side can be used in the synthesis of dual-labelled FRET
probes.
We wish to thank BBSRC and JREI for funding for the Roche
LightCycler, TCS for financial support, and Dr Nicola Thelwell
(Oswel) for helpful comments.
A FRET study was carried out on P1 and P2 hybridised to a
fully complementary oligodeoxynucleotide. but before doing
this we determined the effect of the 2A-modification on duplex
stability. The Tm of the native DNA duplex is 48 °C compared
Notes and references
‡ Compounds were characterised by 1H-NMR, 13C-NMR, MS, IR and mp/
CHN microanalysis or HRMS.
§ The HyBeacon 2DC64C* sequence is dGGGCGFCTGGGGGTGX,
where C = polymorphic site, F = 2A-FAM ethoxy dU, and X = 3A-octanol
PCR stopper). It targets the human CYP2D6 4 mutation in which there is a
G to A transition at position 1846. It matches the wild-type sequence (*1,
C.G base pair) and is mismatched to the mutant (*4, C.A base pair).
¶ The protocols for PCR were taken from previous work on HyBeacons.4,6
Aminolink and 6-FAM Phosphoramidites were purchased from Trans-
genomics Ltd, West of Scotland Science Park, Glasgow, UK. NHS 6-ROX
was purchased from Molecular Probes Inc (www.probes.com).
1 K. J. Livak, S. A. J. Flood, J. Marmaro, W. Giusti and K. Deetz, PCR
Methods and Applications, 1995, 357.
2 D. Whitcombe, J. Theaker, S. P. Guy, T. Brown and S. Little, Nature
Biotech., 1999, 17, 804.
3 S. Tyagi and F. R. Kramer, Nature Biotech., 1995, 14, 303.
4 D. J. French, C. L. Archard, T. Brown and D. G. McDowell, Mol. Cell
Probes, 2001, 15, 363.
5 D. J. French, D. G. McDowell and T. Brown, International patent
application WO 0173118, 2001.
6 D. J. French, C. L. Archard, M. T. Andersen and D. G. McDowell, Mol.
Cell Probes, 2002, 16, 319.
Scheme 2 Oligonucleotide synthesis.
7 K. Yamana, T. Mitsui, H. Hayashi and H. Nakano, Tetrahedron Lett.,
1997, 38, 5815.
8 K. Yamana, Y. Ohashi, K. Nunota and H. Nakano, Tetrahedron, 1997,
53, 4265.
9 K. Yamana, T. Mitsui and H. Nakano, Tetrahedron, 1999, 55, 9143.
10 L. J. Brown, J. P. May and T. Brown, Tetrahedron Lett., 2001, 42,
2587.
11 M. Krecmerova, H. Hrebabecky and H. Antonin, Collect. Czech. Chem.
Commun., 1996, 61, 645.
12 A. Solinas, L. J. Brown, C. McKeen, J. M. Mellor, J. T. G. Nicol, N.
Thelwell and T. Brown, Nucleic Acids Res., 2001, 29, e96.
13 M. A. Ali and S. A. Ahmed, J. Chem. Phys., 1988, 90, 1484.
14 R. A. Cardullo, S. Agrawal, C. Flores, P. C. Zamecnik and D. E. Wolf,
Proc. Natl. Acad. Sci. U. S. A., 1988, 85, 8790.
Fig. 2 Post-PCR fluorescence melting analysis using 2DC64C* HyBeacon.
Data acquired over 15 min. Red: fully complementary homozygous
template; Green: heterozygote; Blue: mutant; Black: negative control (no
template DNA).
CHEM. COMMUN., 2003, 1234–1235
1235